PharmaCyte Biotech PMCB Stock Buy or Sell Rhythm Pharmaceuticals RYTM Stock Trend Direction Analysis Q4 2025 Profit Exceeds Views AHMA Ambitions leadership outlines core revenue growth drivers and looming industry headwinds following latest quarterly earnings release SUPV Grupo reports significantly wider Q4 2025 loss than expected shares post small gain WF Woori posts 55 Q4 2025 EPS miss against analyst forecasts sending shares down nearly 5 today